FindMyRecallSubscribe
Class I: serious health riskTerminated

Positive Health RISE UP RED EDITION Capsules Recall

RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08J…

Positive Health · Wilmington, DE

Risk level
Class I
Reported by FDA
Mar 2, 2022
Recall ID
D-0645-2022
Check your lot numberHow we source this data

Summary

Positive Health recalled RISE UP RED EDITION Capsules starting Feb 10, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0645-2022 on Mar 2, 2022. Reason: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1.

Lot numbers, UPCs & expiration codes

Lot # 48658908, Exp. date 09/09/2023

Where it was sold

Product was distributed nationwide via the internet through Amazon Marketplace.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0645-2022
Classification
Class I
Status
Terminated
Recall initiated
Feb 10, 2022
FDA report date
Mar 2, 2022
Quantity
5,500 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Positive Health

Original FDA data

Every field from FDA enforcement report D-0645-2022, exactly as published.

Show all FDA fields
City
Wilmington
State
DE
Status
Terminated
Country
United States
Event ID
89606
Address
1013 Centre Rd
Address (line 2)
Suite 403B
Code information
Lot # 48658908, Exp. date 09/09/2023
Postal code
19805-1265
Report date
Mar 2, 2022
Product type
Drugs
Recall number
D-0645-2022
Classification
Class I
Recalling firm
Positive Health
Product quantity
5,500 cartons
Termination date
Jun 3, 2022
Reason for recall
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1.
Distribution pattern
Product was distributed nationwide via the internet through Amazon Marketplace.
Recall initiation date
Feb 10, 2022
Initial firm notification
Press Release
Center classification date
Mar 4, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0645-2022, published Mar 2, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls